From: Asthma
No exacerbations |
Fewer than 3Â doses/week of a rapid-acting beta2-agonist bronchodilator |
Daytime symptoms < 3 days/week |
No nighttime symptoms |
Normal physical activity |
No absenteeism from work or school |
FEV1 or PEF at least 90% of personal best |